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LEPTOSPIROSIS
Fact Sheet for Clinicians
Background
• Leptospirosis is a disease that is caused by 
spirochete bacteria in the genus Leptospira. 
There are 10 pathogenic species, and more 
than 250 pathogenic serovars.
• While leptospirosis occurs worldwide, it is 
more common in tropical or sub-tropical 
climates. 
• It is estimated that more than 1 million cases 
occur worldwide annually, including almost 
60,000 deaths. 
• In the United States, approximately 
100–150 leptospirosis cases are reported 
annually. Puerto Rico reports the majority of 
leptospirosis cases, followed by Hawaii.
• Outbreaks of leptospirosis tend to occur 
after heavy rainfall or flooding in endemic 
areas, especially areas with poor housing 
and sanitation conditions.
Transmission
• Leptospires are spread 
by the urine of infected 
animals (rodents, dogs, 
livestock, pigs, horses, 
wildlife).
• The bacteria can survive 
for weeks to months in 
urine-contaminated 
water and soil.
• People can be infected through
 » Direct contact with the urine or reproductive 
fluids from infected animals
 » Contact with urine-contaminated water 
(floodwater, rivers, streams, sewage) and 
wet soil
 » Ingestion of food or water contaminated 
by urine or urine-contaminated water
• Transmission occurs through mucous 
membranes, conjunctiva, and skin cuts 
or abrasions. 
• Human-to-human transmission is very rare 
but has been documented through sexual 
intercourse and breastfeeding. Transmission 
has also rarely occurred through animal bites.
• High-risk activities can include wading, 
swimming, or boating in floodwater or 
freshwater (rivers, streams, lakes) that 
may be contaminated with animal urine. 
Some actions like prolonged immersion 
in, submerging head in, or swallowing 
contaminated water can particularly 
increase risk. 
• Other high risk activities can include direct 
contact with animals and activities that can 
lead to skin abrasions and water or soil 
exposure, such as clearing brush, trekking, 
and gardening.
Leptospira spp. bacteria 
Clinical Findings
• Incubation period is 2–30 days; most illnesses occur 5–14 
days after exposure.
• Most infections are thought to be asymptomatic. 
• Approximately 90% of clinical illnesses present as a non-
specific acute febrile illness, while approximately 10% 
progress to severe, potentially fatal illness with multi-organ 
dysfunction. 
• Illness may be biphasic, with the patient briefly recovering 
from mild illness, but then developing more severe illness.
• Symptoms can include fever, headache, myalgia (typically 
of the calves and lower back), conjunctival suffusion, 
nausea, vomiting, diarrhea, abdominal pain, cough, and 
sometimes a skin rash.
• Severe symptoms can include jaundice, renal failure, 
hemorrhage (especially pulmonary), aseptic meningitis, 
cardiac arrhythmias, pulmonary insufficiency, and 
hemodynamic collapse. Combined renal and liver failure 
associated with leptospirosis is referred to as Weil’s 
disease.
• Leptospirosis during pregnancy can cause fetal 
complications including fetal death or abortion.
• The case fatality rate for leptospirosis is approximately 
5%–15% among patients with severe illness. Among 
patients with severe pulmonary hemorrhagic syndrome, 
the case fatality rate can exceed 50%.
Treatment
Early treatment may decrease 
the severity and duration 
of disease. In patients with 
a high clinical suspicion of 
leptospirosis, initiating antibiotic 
treatment as soon as possible 
without waiting for laboratory 
results is recommended.
• For patients with mild 
symptoms, doxycycline 
is the drug of choice (100 
mg orally, twice daily), if 
not contraindicated. Other 
options include azithromycin 
(500 mg orally, once daily), 
ampicillin (500-750 mg orally, 
every 6 hours), amoxicillin 
(500 mg orally, every 6 hours).
• For patients with severe 
disease, IV penicillin is 
the drug of choice (1.5 
MU IV, every 6 hours), and 
ceftriaxone (1 g IV, every 
24 hours) can be equally 
effective.  
Laboratory Testing
• Antibodies for leptospirosis develop 
between 3-10 days after symptom onset, 
thus any serologic test must be interpreted 
accordingly – negative serologic test results 
from samples collected in the first week 
of illness do not rule out disease, and 
serologic testing should be repeated on a 
convalescent sample collected 7-14 days 
after the first. 
• In the acute phase of illness, leptospires 
are present in the blood (septicemia) for 
approximately the first 4–6 days of illness.  
 
Leptospires may be shed intermittently in 
the urine after approximately the first week 
of illness onset. Due to the transience of 
leptospires in body fluids, a negative PCR 
test does not rule out leptospisosis.
• It is best to submit as many specimen 
types as possible. Recommended 
specimens based on collection timing:
 » Acute illness (first week): whole blood 
and serum
 » Convalescent illness (after first week): 
serum +/- urine
Supportive Diagnostic Tests 
• IgM-based commercial assays, such as
 » ELISA IgM
 » ImmunoDOT
 » Lateral flow tests
• IgM assays are screening tests and 
results should be confirmed using one 
of the confirmatory methods below.
Confirmatory Diagnostic Tests
1. Microscopic agglutination test (MAT) — confirmatory serologic testing, available at CDC
 » Acute and convalescent serum samples collected 7–14 days apart is ideal. 
 » If only one serum sample can be sent for testing, a sample collected after the first 
7–10 days of illness is preferred.
2. Polymerase chain reaction (PCR) – available at CDC and some commercial labs
Recommended samples
 » Whole blood collected in the first week of illness (in the first 4 days is ideal) 
 » Urine (collected at least 1 week after symptom onset is ideal)
 » Cerebrospinal fluid from a patient with signs of meningitis
 » Fresh frozen kidney and/or liver (if available from deceased patients) — kidney preferred
3. Pathology (immunohistochemistry) — available at CDC
 » Formalin-fixed tissues: from the kidney (preferred), liver, lung, heart, or spleen
Sample Submission
To submit specimens to CDC for confirmatory 
testing, or if you have questions regarding 
leptospirosis diagnostic testing, contact CDC-
INFO at 800-232-4636.  Information on sample 
submission, including the sample submission form 
(DASH Form 50.34) and shipping instructions can 
be found at: http://www.cdc.gov/ncezid/dhcpp/
bacterial_special/zoonoses_lab.html.
Unless authorized to send directly to 
CDC, all specimens should be sent 
and processed through the state/
territorial public health laboratory.
Prevention
• The first line of leptospirosis prevention is to 
avoid exposure. 
• Avoid wading, swimming, bathing, 
swallowing, or submersing head in 
potentially contaminated freshwater (rivers, 
streams) especially after periods of heavy 
rainfall or flooding. 
• Avoid contact with floodwater, and do not 
eat food contaminated with floodwater.
• If exposure cannot be avoided, wear 
appropriate personal protective equipment 
(PPE) (rubber boots, waterproof coveralls/
clothing, gloves). Cover open wounds with 
waterproof dressings. 
• Treat unsafe or potentially contaminated 
drinking water by boiling or chemically 
treating.
• Keep rodent populations (rats and mice) or 
other animal pests under control. Do not 
eat food that may have been exposed to 
rodents and possibly contaminated with 
their urine.
• Some studies have shown that 
chemoprophylaxis with doxycycline might 
be effective in preventing clinical disease 
and could be considered for people at high 
risk and with short-term exposures.
Surveillance and Reporting
• Leptospirosis is a nationally notifiable 
disease. 
• The Council of State and Territorial 
Epidemiologists (CSTE) leptospirosis case 
definition can be found at: https://wwwn.
cdc.gov/nndss/conditions/leptospirosis/
case-definition/2013/. Please note the 
difference between laboratory tests 
that are “supportive” of a “probable” 
case classification versus those that 
provide evidence for a “confirmed” case 
classification.
• Please report confirmed and probable cases 
of leptospirosis to CDC via your state/
territorial health department using the CDC 
leptospirosis case report form found at: 
https://www.cdc.gov/leptospirosis/health_
care_workers/index.html
For more information about leptospirosis, call 
1-800-CDC-INFO or visit www.cdc.gov/leptospirosis.
